scientific journal | Q5633421 |
P8375 | Crossref journal ID | 80019 |
P1058 | ERA Journal ID | 40379 |
P236 | ISSN | 1874-4737 |
1874-4745 | ||
P7363 | ISSN-L | 1874-4737 |
P1055 | NLM Unique ID | 101468123 |
P856 | official website | http://www.benthamscience.com/cdar/index.htm |
P10283 | OpenAlex ID | S129558293 |
P3181 | OpenCitations bibliographic resource ID | 21714 |
P7662 | Scilit journal ID | 614418 |
P1156 | Scopus source ID | 18400156715 |
P495 | country of origin | Kingdom of the Netherlands | Q29999 |
P8875 | indexed in bibliographic review | Scopus | Q371467 |
P407 | language of work or name | English | Q1860 |
P123 | publisher | Bentham Science Publishers | Q2896740 |
P1366 | replaced by | Current drug research reviews | Q59491846 |
P1476 | title | Current Drug Abuse Reviews |
Q37895290 | "Legal highs" - new players in the old drama |
Q37561254 | "My drink is larger than yours"? A literature review of self-defined drink sizes and standard drinks |
Q37561273 | "Speed" warps time: methamphetamine's interactive roles in drug abuse, habit formation, and the biological clocks of circadian and interval timing |
Q22241316 | A Review of Lysergic Acid Diethylamide (LSD) in the Treatment of Addictions: Historical Perspectives and Future Prospects |
Q39125690 | A Review of the Physiological Factors Associated with Alcohol Hangover |
Q39104303 | A Review on the Sex differences in Organ and System Pathology with Alcohol Drinking |
Q38587528 | A Systematic Review of Digital and Computer-Based Alcohol Intervention Programs in Primary Care |
Q37681004 | A critical review of laboratory-based studies examining the relationships of social anxiety and alcohol intake |
Q37893175 | A critical review of treatment approaches for gambling disorders |
Q41618368 | A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment. |
Q38308999 | A review of lysergic acid diethylamide (LSD) in the treatment of addictions: historical perspectives and future prospects |
Q37029260 | A review of preclinical research demonstrating that drug and non-drug reinforcers differentially affect behavior |
Q37780252 | A review of the next day effects of alcohol on subjective mood ratings |
Q34175943 | A review of the psychometric properties of the CRAFFT instrument: 1999-2010. |
Q37561225 | Alcohol abuse, immunosuppression, and pulmonary infection. |
Q37997829 | Alcohol and cognition - consideration of age of initiation, usage patterns and gender: a brief review. |
Q87047108 | Alcohol hangover and the workplace: a need for research |
Q37742658 | Alcohol use and cataract |
Q37101887 | Alcohol use in the Greek system, 1999-2009: a decade of progress. |
Q44528361 | Alcohol, drugs, and diving: implications for health and fitness to dive |
Q42761476 | Alcoholism's evolutionary and cultural origins |
Q37965834 | Alcoholism, personality, and religion/spirituality: an integrative review |
Q37561221 | Alterations in homocysteine metabolism among alcohol dependent patients--clinical, pathobiochemical and genetic aspects |
Q37580649 | An Essential Role for Adenosine Signaling in Alcohol Abuse |
Q26829172 | An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research |
Q43309828 | Analysis of urine from pooled urinals - a novel method for the detection of novel psychoactive substances |
Q37561216 | Are some drinkers resistant to hangover? A literature review. |
Q37561205 | Associative learning, the hippocampus, and nicotine addiction |
Q55887025 | Ayahuasca, Psychedelic Studies and Health Sciences: The Politics of Knowledge and Inquiry into an Amazonian Plant Brew |
Q30370469 | Ayahuasca, psychedelic studies and health sciences: the politics of knowledge and inquiry into an Amazonian plant brew. |
Q44956187 | Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada |
Q37826205 | Behavioral and neurochemical studies in distinct animal models of ethanol's motivational effects. |
Q37561313 | Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties |
Q27024840 | Binge eating disorder and food addiction |
Q37826203 | Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood-brain barrier. |
Q35160035 | Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review |
Q38089180 | Buprenorphine and buprenorphine/naloxone intoxication in children - how strong is the risk? |
Q36394429 | Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives |
Q41588740 | Caffeine consumption in children, adolescents and adults. |
Q38587529 | Can Decision Making Research Provide a Better Understanding of Chemical and Behavioral Addictions? |
Q34341809 | Can MDMA play a role in the treatment of substance abuse? |
Q34239091 | Cannabinoid hyperemesis syndrome |
Q86521607 | Cannabis concerns: increased potency, availability and synthetic analogues |
Q52313563 | Cannabis: an overview of its adverse acute and chronic effects and their implications. |
Q37709462 | Cardioprotection by regular ethanol consumption: potential mechanisms and clinical application |
Q37678558 | Carisoprodol: abuse potential and withdrawal syndrome |
Q38090713 | Cigarette smoking in methadone maintained patients: an up-to-date review |
Q58229990 | Clinical and Forensic Signs Related to Opioids Abuse |
Q37978930 | Clinical and forensic signs related to cocaine abuse. |
Q38061434 | Clinical and forensic signs related to opioids abuse |
Q37997826 | Cocaine and acute vascular diseases. |
Q28290551 | Cognitive and psychomotor performance during alcohol hangover |
Q48173575 | Cognitive enhancing drugs: a blessing for society? |
Q48555897 | Cognitive function in ecstasy naive abstinent drug dependants and MDMA users. |
Q34734256 | Cognitive processes in alcohol binges: a review and research agenda |
Q38662983 | Combining Stress and Dopamine Based Models of Addiction: Towards a Psycho-Neuro-Endocrinological Theory of Addiction |
Q38008709 | Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations. |
Q37561309 | Contingency management for smoking cessation: where do we go from here? |
Q28297777 | Could Sigma Receptor Ligands be a Treatment for Methamphetamine Addiction? |
Q41618352 | Crisis intervention related to the use of psychoactive substances in recreational settings--evaluating the Kosmicare Project at Boom Festival |
Q39081968 | Cultivating a trauma awareness culture in the addictions. |
Q84289254 | Current drug abuse--time to be reviewed |
Q38260856 | Current management of alcoholic liver disease |
Q38008707 | Current trends in using Internet and mobile technology to support the treatment of substance use disorders. |
Q45920639 | DUI recidivism: an ongoing traffic safety concern. |
Q37807447 | Deterioration of Executive Functioning in Chronic Ecstasy Users: Evidence for Multiple Drugs Effects |
Q37807448 | Development of Tamper Deterrent Formulations: State of the Pharmaceutical Industry |
Q47796273 | Development of a Definition for the Alcohol Hangover: Consumer Descriptions and Expert Consensus |
Q38037679 | Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance. |
Q33347468 | Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery? |
Q35626202 | Does anorexia nervosa resemble an addiction? |
Q37915543 | Dopamine neurons in the ventral tegmental area: drug-induced synaptic plasticity and its role in relapse to drug-seeking behavior |
Q38308984 | Drivers' visual scanning impairment under the influences of alcohol and distraction: a literature review. |
Q86039231 | Driving while hungover: the necessity of biomarkers of the alcohol hangover state |
Q37561349 | Drug abuse, brain calcification and glutamate-induced neurodegeneration |
Q37561367 | Drug reinforcement in a rat model of attention deficit/hyperactivity disorder--the Spontaneously Hypertensive Rat (SHR). |
Q49553665 | Drug-Drug Interactions in cocaine-users and their clinical implications |
Q37915544 | Drug-related death following release from prison: a brief review of the literature with recommendations for practice |
Q34175949 | Drug-related decrease in neuropsychological functions of abstinent drug users |
Q37678561 | Drugs of abuse, driving and traffic safety |
Q42915061 | Editorial [ The Importance of Raising the Profile of Alcohol Hangover Research ] |
Q89163248 | Editorial: Asleep at the Wheel: Concerning Driving after Co-Consumption of Alcohol and Benzodiazepines |
Q54262190 | Editorial: Can hangover immunity be really claimed? |
Q85735952 | Editorial: Cognitive enhancement: are we barking up the wrong tree? |
Q52306456 | Editorial: Introduction to 'beneficial effects of psychedelics with a special focus on addictions'. |
Q52301644 | Editorial: Mobile technology and naturalistic study designs in addiction research. |
Q53082945 | Editorial: Second International Conference on Novel Psychoactive Substances (NPSs): keynote addresses and conference abstracts. |
Q83765356 | Editorial: The need for an effective hangover cure |
Q44533982 | Editorial: US students' alcohol consumption: a downward trend, but increased concerns. |
Q56609214 | Editorial: [The “Hair of the Dog”: A Useful Hangover Remedy or a Predictor of Future Problem Drinking?] |
Q37893174 | Effect of the monoamine oxidase inhibition on rewarding effects of nicotine in rodents |
Q38067769 | Efficacy of contingency management for cocaine dependence treatment: a review of the evidence. |
Q37997828 | Efficacy of group treatments for alcohol use disorders: a review |
Q38202159 | Enriched environments for rodents and their interaction with nicotine administration |
Q54375428 | Epidemiology of illicit drug use and policy evaluation. |
Q47941254 | Estimates of cocaine use in Milan |
Q37561332 | Ethanol withdrawal and hyperalgesia. |
Q37962648 | Evidence-based pharmacological treatment of substance use disorders and pathological gambling |
Q36263829 | Executive Functioning in Alcohol Use Studies: A Brief Review of Findings and Challenges in Assessment |
Q52299909 | Food and addiction: implications and relevance to eating disorders and obesity. |
Q28972223 | Forced Abstinence Model of Relapse to Study Pharmacological Treatments of Substance Use Disorder |
Q30409923 | From QTL to candidate gene: a genetic approach to alcoholism research |
Q30902658 | Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review |
Q44335636 | Generation RX: adolescent prescription drug abuse |
Q37561294 | HIV sex risk behaviors among heterosexual methamphetamine users: literature review from 2000 to present |
Q28290604 | Hangover and risk for alcohol use disorders: existing evidence and potential mechanisms |
Q33579210 | Hangover research needs: proceedings of the 5th Alcohol Hangover Research Group meeting |
Q37561259 | Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects |
Q88528910 | High Prevalence of Abandoned Needlesticks from Injecting Drug Users in Milton Keynes, UK: Analysing Access to Needle Exchange Centres and Drug Dependency Services |
Q38603220 | How Can Geographical Information Systems and Spatial Analysis Inform a Response to Prescription Opioid Misuse? A Discussion in the Context of Existing Literature. |
Q37742664 | How Internet technology can improve the quality of care for substance use disorders |
Q37183687 | Hypothesis-driven medication discovery for the treatment of psychostimulant addiction |
Q37742667 | IGF-I abuse in sport |
Q34341800 | Ibogaine in the treatment of substance dependence |
Q37561364 | Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences |
Q48253265 | Immunotoxicity of cocaine and crack |
Q37561209 | Incorporating coping into an expectancy framework for explaining drinking behaviour |
Q34239086 | Increasing delta-9-tetrahydrocannabinol (Δ-9-THC) content in herbal cannabis over time: systematic review and meta-analysis |
Q37742661 | Individual differences in novelty-seeking and behavioral responses to nicotine: a review of animal studies |
Q52306910 | Introduction to 'beneficial effects of psychedelics with a special focus on addictions'. |
Q37945761 | Is fast food addictive? |
Q30734138 | Laterality of Brain Activation for Risk Factors of Addiction |
Q46920485 | Length of stay in different drug using states: lifestyles of problem and recreational drug consumers |
Q50077477 | Long-term administration of antipsychotic drugs in schizophrenia and influence of substance and drug abuse on the disease outcome |
Q37561239 | Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research |
Q37893169 | MDMA & cannabis: a mini-review of cognitive, behavioral, and neurobiological effects of co-consumption |
Q37561318 | Measuring the impact of psychoactive substance on health-related quality of life: an update |
Q38045459 | Mechanism of action of methamphetamine within the catecholamine and serotonin areas of the central nervous system |
Q37280041 | Metabotropic glutamate receptor ligands as potential therapeutics for addiction |
Q37561299 | Methadone and the heart: what the clinician needs to know |
Q38114943 | Methadone maintenance treatment and cognitive function: a systematic review |
Q38168892 | Methods for estimating incidence of drug use: a review. |
Q39036695 | Midazolam plus haloperidol as adjuvant analgesics to morphine in opium dependent patients: A randomized clinical trial |
Q37561278 | Modafinil: a useful medication for cocaine addiction? Review of the evidence from neuropharmacological, experimental and clinical studies. |
Q83191345 | Monitoring drugs of abuse in wastewater and air |
Q30708661 | Monitoring the size and protagonists of the drug market: combining supply and demand data sources and estimates |
Q37561354 | Negative affect and drinking drivers: a review and conceptual model linking dissonance, efficacy and negative affect to risk and motivation for change |
Q37561229 | Neurobiological and psychosocial processes associated with depressive and substance-related disorders in adolescents |
Q34906263 | Neuropharmacology of the interoceptive stimulus properties of nicotine. |
Q37807449 | Neuropsychological aspects of dual diagnosis |
Q37561360 | Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research. |
Q38308979 | Older adults prescribed methadone: a review of the literature across the life span from opiate initiation to methadone maintenance treatment. |
Q43435049 | On illicit drug policies; methods of evaluation and comments on recent practices |
Q34993948 | Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review |
Q38260858 | Opioid neonatal abstinence syndrome: controversies and implications for practice. |
Q37945758 | Overlaps in the nosology of substance abuse and overeating: the translational implications of "food addiction". |
Q35972094 | Pain and Opioid Addiction: A Systematic Review and Evaluation of Pain Measurement in Patients with Opioid Dependence on Methadone Maintenance Treatment |
Q56919646 | Pain-prescription differences – an analysis of 500,000 discharge summaries |
Q37561323 | Parallel roles for dopamine in pathological gambling and psychostimulant addiction |
Q38201522 | Pavlovian sign-tracking model of alcohol abuse |
Q33880993 | Phasic dopamine release in appetitive behaviors and drug addiction |
Q37893171 | Phosphodiesterase type 5 inhibitor abuse: a critical review |
Q37561337 | Phytocannabinoids and endocannabinoids |
Q38746244 | Pleasure as an Overlooked Target of Substance Use Disorder Research and Treatment |
Q37561242 | Policy and health implications of using the U.S. Food and Drug Administration product design approach in reducing tobacco product risk |
Q37561263 | Potential role of ADAMTS13 in the progression of alcoholic hepatitis |
Q38776474 | Proceeding of the 8th Alcohol Hangover Research Group Meeting. |
Q50179945 | Proceeding of the 9th Alcohol Hangover Research Group Meeting |
Q35126018 | Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. |
Q38309004 | Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca. |
Q39884037 | Psychosocial Predictors of Relapse Among Patients with Alcohol Problems |
Q37362242 | Putative role of brain acetaldehyde in ethanol addiction |
Q26823375 | Quantifying reinforcement value and demand for psychoactive substances in humans |
Q47928553 | Quitters Never Sleep: The Effect of Nicotine Withdrawal Upon Sleep |
Q37638323 | Recent advances in understanding the personality underpinnings of impulsive behavior and their role in risk for addictive behaviors. |
Q37561268 | Recent developments in the treatment of alcoholic chronic pancreatitis |
Q37826204 | Recent topics on pharmacotherapy for amphetamine-type stimulants abuse and dependence |
Q37965832 | Recreational drug misuse and stroke |
Q37945763 | Regulation of drug and palatable food overconsumption by similar peptide systems. |
Q27694528 | Reinforcement pathology and obesity |
Q43054892 | Response conflict as an environmental determinant of gender differences in sensitivity to alcohol impairment |
Q34993955 | Review of topiramate: an antiepileptic for the treatment of alcohol dependence |
Q30449968 | Review of treatment for cocaine dependence |
Q38008708 | Reward-seeking behavior and addiction: cause or cog? |
Q47593337 | Role of Repetitive Transcranial Magnetic Stimulation (rTMS) in Treatment of Addiction and Related Disorders: A Systematic Review |
Q38185701 | Role of ghrelin in drug abuse and reward-relevant behaviors: a burgeoning field and gaps in the literature |
Q37561283 | Role of mu and delta opioid receptors in alcohol drinking behaviour |
Q37997827 | Romantic relationships and alcohol use. |
Q38102769 | Salvia divinorum: a psychopharmacological riddle and a mind-body prospect |
Q38308992 | Salvinorin a and related compounds as therapeutic drugs for psychostimulant-related disorders |
Q37945765 | Screening American Indian/Alaska natives for alcohol abuse and dependence in medical settings |
Q38603217 | Signs and Related Mechanisms of Ethanol Hepatotoxicity. |
Q38067768 | Single chemical entity legal highs: assessing the risk for long term harm. |
Q50673189 | Sizing the cannabis market: a demand-side and user-specific approach in seven European countries. |
Q38834402 | Smoking and Cognition |
Q44964626 | Smoking and drinking go hand in hand |
Q36904258 | Smoking cessation for adolescents: a review of pharmacological and psychosocial treatments |
Q38110573 | Smoking cessation in people with schizophrenia |
Q38662980 | Social Inequality and Substance Use and Problematic Gambling Among Adolescents and Young Adults: A Review of Epidemiological Surveys in Germany |
Q37893177 | Sports participation and alcohol use among adolescents: the impact of measurement and other research design elements |
Q22241323 | Studying the Effects of Classic Hallucinogens in the Treatment of Alcoholism: Rationale, Methodology, and Current Research with Psilocybin |
Q37742671 | Substance abuse and movement disorders |
Q34303433 | Substance of abuse and movement disorders: complex interactions and comorbidities |
Q38918952 | Substance-Related and Addictive Disorders as a Risk Factor of Suicide and Homicide among Patients with ADHD: A Mini Review |
Q37945767 | Substance-induced psychoses: a critical review of the literature |
Q38067767 | Substance-related disorders and somatic symptoms: how should clinicians understand the associations? |
Q38005220 | Synthetic cannabinoids as drugs of abuse |
Q28252898 | The "hair of the dog": a useful hangover remedy or a predictor of future problem drinking? |
Q84461232 | The 2D:4D digit ratio: a biomarker of alcohol and drug abuse? |
Q38889071 | The Behavioral Profile of methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (PVP) - A Systematic Review |
Q47687994 | The Green Light on Ketamine: Considerations for On-Road Safety. |
Q38530402 | The Misuse of Prescription Opioids: A Threat for Europe? |
Q61639891 | The Need to Move from Describing to Evaluating the Effectiveness of Indigenous Drug and Alcohol Residential Rehabilitation Services: A Systematic Review |
Q38587531 | The Role of Different Aspects of Impulsivity as Independent Risk Factors for Substance Use Disorders in Patients with ADHD: A Review |
Q41811270 | The Role of Glial Cells in Drug Abuse. |
Q37945759 | The addiction potential of hyperpalatable foods |
Q28290562 | The alcohol hangover research group consensus statement on best practice in alcohol hangover research |
Q28290583 | The application of minerals in managing alcohol hangover: a preliminary review |
Q27008392 | The association between alcohol use and sexual risk behaviors among African American women across three developmental periods: a review |
Q28249870 | The changing face of tobacco use among United States youth |
Q37561234 | The chronic effects of cannabis on memory in humans: a review |
Q43073615 | The drinking culture of fraternity and sorority members |
Q37978929 | The efficacy of stepped care models involving psychosocial treatment of alcohol use disorders and nicotine dependence: a systematic review of the literature |
Q37945764 | The face of uncertainty eats |
Q30489302 | The genetic components of alcohol and nicotine co-addiction: from genes to behavior |
Q34993940 | The impact of excessive alcohol use on prospective memory: a brief review |
Q38823599 | The impact of marijuana use on memory in HIV-infected patients: a comprehensive review of the HIV and marijuana literatures |
Q30483190 | The influence of marijuana use on neurocognitive functioning in adolescents |
Q28290593 | The pathology of alcohol hangover |
Q83394497 | The popularity of "legal highs" |
Q86961019 | The potential of psychedelics as a preventative and auxiliary therapy for drug abuse |
Q44466970 | The recent expansion in the Australian cocaine market: who are the new users and what are the harms? |
Q28290544 | The role of beverage congeners in hangover and other residual effects of alcohol intoxication: a review |
Q37561342 | The role of glial cells in drug abuse. |
Q86895759 | The whole is just the sum of its parts: limited polydrug use among the "big three" expensive drugs in the United States |
Q88528908 | Thiamine and Alcohol for Brain Pathology: Super-imposing or Different Causative Factors for Brain Damage? |
Q38587526 | Toward a Developmentally Centered Approach to Adolescent Alcohol and Substance Use Treatment |
Q37561304 | Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders |
Q28290573 | Treatment and prevention of alcohol hangover |
Q26866733 | Treatment of Adolescent Substance Use Disorders and Co-Occurring Internalizing Disorders: A Critical Review and Proposed Model |
Q38260855 | Treatments for co-occurring depression and substance use in young people: a systematic review |
Q34440531 | Turning points in the life course: current findings and future directions in drug use research |
Q27027919 | Understanding the diverse needs of children whose parents abuse substances |
Q37861862 | Unemployment and substance use: a review of the literature (1990-2010). |
Q83784522 | Unjustified Concerns about Energy Drinks |
Q37561249 | Use of caffeine and nicotine in people with schizophrenia |
Q38260859 | Validity of alcohol screening instruments in general population gender studies: an analytical review |
Q34048269 | Variability in reward responsivity and obesity: evidence from brain imaging studies |
Q48389249 | What can neuroscience tell us about the potential of psychedelics in healthcare? How the neurophenomenology of psychedelics research could help us to flourish throughout our lives, as well as to enhance our dying. |
Q34993944 | What constitutes prescription drug misuse? Problems and pitfalls of current conceptualizations |
Q37561327 | Why should we keep the cerebellum in mind when thinking about addiction? |
Q59491846 | Current drug research reviews | replaces | P1365 |
Search more.